» Bayer Pays Millions to Settle Deep Vein Thrombosis Lawsuits

Bayer Pays Millions to Settle Deep Vein Thrombosis Lawsuits

Tampa, FL (Law Firm Newswire) August 20, 2012 – The drug manufacturer Bayer has paid millions of dollars to settle lawsuits involving pulmonary embolism or deep vein thrombosis (DVT).

The lawsuits were filed by women who used the company's Yaz or Yasmin birth control pills and subsequently developed blood clots.

“Pulmonary embolism and DVT are very serious conditions,” said Greg Grambor, a DVT expert and owner of Vascular PRN, a distributor of treatment devices. “While the causes vary, the best method of prevention is compression therapy, which can be accomplished with a variety of venous compression devices, designed for maximum patient safety and comfort.”

DVT occurs when a blood clot forms in the veins of the pelvis or the legs. If the clot breaks free and travels through the bloodstream, it becomes an embolism. Some of the plaintiffs in the Bayer case suffered from pulmonary embolism.

Since 2009, Bayer has faced more than 12,000 lawsuits by women who say that the birth control pills caused harmful side effects. Attorneys for the plaintiffs said that the FDA has linked at least 50 deaths to use of Yaz and Yasmin.

At present, Bayer is only settling the cases that allege pulmonary embolism or DVT. The German drug maker has so far agreed to pay more than $400 million to settle about 1,877 of the lawsuits. Experts predict the company may eventually pay out billions of dollars.

In April, the FDA ordered Bayer and other manufacturers of contraceptives to issue stronger warning labels. Pills that contain drospirenone, a synthetic hormone, must carry labels indicating that the risk of blood clots may triple when the drug is used.

The lawsuits have been consolidated in federal court as multidistrict litigation, and the combined case is currently the largest in the federal court system. The case is in pretrial proceedings in the Southern District of Illinois.

Vascular PRN is known for helping the medical field with foot and leg sequential compression devices, bariatric equipment, and the Skin IQ™ mattress coverlet that drastically helps to prevent these never events. Vascular PRN has decades of experience helping hospitals, nursing homes, surgery centers, and other institutions with their compression therapy rentals and sales. To learn more about a Sequential Compression Device, SCD boots, or the Skin IQ™ coverlet, visit www.vascularprn.com or call 800-886-4331.

Vascular PRN
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
Phone: 800.886.4331


View Larger Map

  • Public Wants Well-Rested Medical Residents to Ensure Safe Patient Care
    A new national poll shows that the vast majority of the American public favors restricting the work shifts of medical residents (also known as resident physicians) to no more than 16 straight hours without sleep, according to a press release from Public Citizen. Importantly, 86% of the public is opposed to lifting the 16-hour cap […]
  • Rapid-Inflation Intermittent Pneumatic Compression for Prevention of Deep Venous Thrombosis
    Eisele R, Kinzl L, Koelsch T:J Bone Joint Surg Am. 89:1050-6, 2007 Over 1800 consecutive inpatients were enrolled in this randomized prospective clinical study. A total of 902 patients were managed with chemoprophylaxis alone and 901 patients received chemoprophylaxis augmented with [VenaFlow] intermittent pneumatic compression (IPC). All patients were Dopplered for evidence of symptomatic and […]
  • Studies have shown that carefully controlled exercise is safe for patients with lymphedema.
    INFORMATION FROM THE NATIONAL CANCER INSTITUTE Exercise does not increase the chance that lymphedema will develop in patients who are at risk for lymphedema. In the past, these patients were advised to avoid exercising the affected limb. Studies have now shown that slow, carefully controlled exercise is safe and may even help keep lymphedema from […]

See other news sources publishing this article. BETA | Tags: , , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required